Skip to Content

Investor Update

Basel 16 October 2009

Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin Application for Approval of Additional Indication of Breast Cancer

Dear Investor,
Please find enclosed a press release by Chugai:

See attached Chugai press release